The tunneled catheter is a mature technology and a commercial commodity

Journal of Vascular Access

Volumn 6, Issue 3, 2005, Pages 137-

  Vazquez, M A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS FISTULA; BLOOD FLOW VELOCITY; BLOOD VESSEL GRAFT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COMMERCIAL PHENOMENA; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMODYNAMICS; HUMAN; MEDICAL TECHNOLOGY; MORBIDITY; NOTE; POSTOPERATIVE THROMBOSIS; SURGICAL MORTALITY; SURGICAL PATIENT; TREATMENT REFUSAL; VASCULAR ACCESS; VASCULAR PATENCY;

EID: 29444438629     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.1177/112972980500600326     Document Type: Note

References (7)

1. National Kidney Foundation. K/ DOQI Clinical practice guidelines for hemodialysis adequacy. Am J Kidney Dis 2001; 37 (suppl 1): S137-81.
2. Schwab S, BeathardG. The hemodialysis catheter conundrum: hate living with them, but can't live without them. Kidney Int 1999; 56: 1-17.
3. Butterfly D, Schwab S. Catheter access for hemodialysis: an overview. Semin Dial 2001; 14: 411-5.
4. Depner T. Catheter performance. Semin Dial 2001, 14: 425-31.
5. Schon D, Whittman D. Managing the complications of long-term tunneled dialysis catheters. Semin Dial 2003; 16: 314-22.
6. Oliver M, Rothwell D, Fung K, et al. Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol 2004; 15: 1936-42.
7. Astor B, Eustace J, Powe N, et al. Type of vascular access and survival among incident hemodialysis patients: the choices for healthy outcomes in caring for ESRD (CHOICE) study. J Am Soc Nephrol 2005; 16: 1449-55.